Genen­tech de­tails claims Sanofi part­ner JHL used stolen trade se­crets to de­vel­op ri­val drugs at an 'as­ton­ish­ing pace'

The feds re­cent­ly round­ed up and charged a group of four, in­clud­ing a long­time se­nior sci­en­tist, with steal­ing trade se­crets from Genen­tech in South San Fran­cis­co. But it’s the com­pa­ny they were al­leged­ly work­ing for — Tai­wan’s JHL Biotech, close­ly part­nered with Sanofi — that has in­spired the big Roche sub­sidiary’s wrath.

In a de­tailed law­suit filed in fed­er­al court, Genen­tech spelled out what it says was a scheme by JHL to steal a march on in­dus­try ri­vals in de­vel­op­ing biosim­i­lars of Rit­ux­an, Her­ceptin and Avastin. And they are af­ter an in­junc­tion to shut it down.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER